Abstract
To investigate whether (1 → 3)-β-d-Glucan (BDG)-guidance shortens time to antifungal therapy and thereby reduces mortality of sepsis patients with high risk of invasive Candida infection (ICI).
Leibniz-HKI-Authors
Identifier
doi: 10.1007/s00134-022-06733-x
PMID: 35708758